Hims & Hers Health (NYSE:HIMS) priced its offering of $870M aggregate principal amount of 0.00% convertible senior notes due ...

Hims & Hers offers rare high growth at value pricing, with DCF models pointing to major upside despite volatility and short ...

Hims & Hers rebounds with key partnerships and launches, achieving 111% YoY revenue growth. Learn more about HIMS stock here.

Shares of Hims & Hers have gained 29% over the past week. The move higher has been driven by an impressive Q1 earnings report ...

CEO Andrew Dudum said the funds will allow the company to grow internationally and invest in artificial intelligence.

Former Meta and Time Warner exec Mark D’Arcy is joining Microsoft as a corporate vice president working on the tech giant’s ...

Stocktwits - Shares of Hims & Hers Health, Inc. (HIMS) surged nearly 16% in Tuesday’s regular session and extended gains in ...

Hims & Hers (NYSE: HIMS) stock has been on fire in 2025, and the company just got more great news after upsizing a $450 million convertible debt offering to up to $1 billion. The growth of Hims & Hers ...

Here's why these two growth stocks scan as no-brainer buys right now. An emerging powerhouse in telehealth Hims & Hers Health ...

Hims & Hers Health (NYSE:HIMS) experienced a remarkable 97% share price increase over the past month, a move that coincided with significant executive changes. The appointment of Mo Elshenawy as ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...